PD-L2 expression by tumor cells was also observed in lung cancer, where it is usually associated with the detection of other immune checkpoint molecules (PD-L1, indoleamine-pyrrole 2,3-dioxygenase, others). Here, PDCD1LG2 is linked to lung cancer.